Evidence map›Paper›PMID 22024166›Full record

ArticleThe Journal of cell biology2011

Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway.

Mee-Sup Yoon, Guangwei Du, Jonathan M Backer, Michael A Frohman, Jie Chen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 151 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Regulation of mTOR by phosphatidic acid.Trends in endocrinology and metabolism: TEM · 2023
    Review
  6. New Insights into the Regulation of mTOR Signaling via CaInternational journal of molecular sciences · 2023
    Review
  7. Review
  8. Phosphoinositides as membrane organizers.Nature reviews. Molecular cell biology · 2022
    Review
  9. Article
  10. Article
  11. Self-transducible LRS-UNE-L peptide enhances muscle regeneration.Journal of cachexia, sarcopenia and muscle · 2022
    Article
  12. Lysosomes at the Crossroads of Cell Metabolism, Cell Cycle, and Stemness.International journal of molecular sciences · 2022
    Review
  13. Class III PI3K Biology.Current topics in microbiology and immunology · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Amino Acid-Mediated Intracellular CaInternational journal of molecular sciences · 2021
    Article
  18. Article
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Mee-Sup YoonDepartment of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Guangwei Du
Jonathan M Backer
Michael A Frohman
Jie Chen
University of Illinois Urbana-Champaign · USStony Brook University · USThe University of Texas Health Science Center at Houston · USYeshiva University · US

Funding

mTOR Signaling in Skeletal MyogenesisR01AR048914 · NIAMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHEN, JIE · 2003 to 2019
$4.8M
P85/P110 PI 3 KINASE--STRUCTURE/FUNCTION AND PHYSIOLOGYR01GM055692 · NIGMS · YESHIVA UNIVERSITY · PI BACKER, JONATHAN M. · 1997 to 2013
$4.4M
Phospholipase D signalingR01GM089771 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHEN, JIE · 2011 to 2025
$3.9M
Lipid-signaling pathways regulating mitochondrial morphology, energetics, and movR01GM084251 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 2009 to 2017
$2.6M
Roles of Phospholipase D in AT1 Receptor EndocytosisR01GM071475 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DU, GUANGWEI · 2006 to 2010
$1.6M
NIAMS NIH HHS AR048914NIAMS NIH HHS R01 AR048914NIDDK NIH HHS DK007069NIGMS NIH HHS GM055692NIGMS NIH HHS GM071475NIGMS NIH HHS GM084251NIGMS NIH HHS GM089771NIGMS NIH HHS R01 GM055692NIGMS NIH HHS R01 GM071475NIGMS NIH HHS R01 GM084251NIGMS NIH HHS R01 GM089771
6 · The paper itself

Abstract

The rapamycin-sensitive mammalian target of rapamycin (mTOR) complex, mTORC1, regulates cell growth in response to mitogenic signals and amino acid availability. Phospholipase D (PLD) and its product, phosphatidic acid, have been established as mediators of mitogenic activation of mTORC1. In this study, we identify a novel role for PLD1 in an amino acid-sensing pathway. We find that amino acids activate PLD1 and that PLD1 is indispensable for amino acid activation of mTORC1. Activation of PLD1 by amino acids requires the class III phosphatidylinositol 3-kinase hVps34, which stimulates PLD1 activity through a functional interaction between phosphatidylinositol 3-phosphate and the Phox homology (PX) domain of PLD1. Furthermore, amino acids stimulate PLD1 translocation to the lysosomal region where mTORC1 activation occurs in an hVps34-dependent manner, and this translocation is necessary for mTORC1 activation. The PX domain is required for PLD1 translocation, mTORC1 activation, and cell size regulation. Finally, we show that the hVps34-PLD1 pathway acts independently of, and in parallel to, the Rag pathway in regulating amino acid activation of mTORC1.

Indexed as

Signal TransductionAmino AcidsClass III Phosphatidylinositol 3-KinasesHEK293 CellsHumansMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylinositol PhosphatesPhospholipase DProteinsTOR Serine-Threonine KinasesAmino AcidsClass III Phosphatidylinositol 3-KinasesMechanistic Target of Rapamycin Complex 1Multiprotein Complexesphosphatidylinositol 3-phosphatePhosphatidylinositol PhosphatesPhospholipase Dphospholipase D1ProteinsTOR Serine-Threonine Kinases

Identifiers

PMID22024166
PMCPMC3206351
OpenAlexW2119392009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.